Wouter V Vogel

11PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Foetal development and medicinePredictive and prognostic markersInnate immunityPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 27, 2026
PROQURE-I: a phase I study adding concurrent [177Lu]Lu-PSMA-617 to EBRT and ADT in curative intent treatment of N1 prostate cancer.

|Mar 17, 2026
Smart scanning for two: [18F]FDG dose optimization for pregnant patients using LAFOV PET/CT technology.

Ilja S Deurloo, Milou M Steemers-de Boer, Johannes H van Snick

|Oct 28, 2025
[18F]FDG-PET/CT's change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial.

Sabine E Breukers, Robert D Crommelin, Laura A Smit

|May 27, 2025
Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?

Bernies van der Hiel, Wouter V Vogel, Alfons J M van den Eertwegh

|Apr 28, 2022
Characteristics of tumour stroma in regional lymph node metastases in colorectal cancer patients: a theoretical framework for future diagnostic imaging with FAPI PET/CT.

Meaghan Polack, Sophie C Hagenaars, Alice Couwenberg

|Dec 27, 2021
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.

Joris L Vos, Charlotte L Zuur, Laura A Smit

Pageof 2

Frequent Collaborators

2 joint publications

Arthur J A T Braat

2 joint publications

Berlinda J de Wit-van der Veen

1 joint publications

P K de Koekkoek-Doll

1 joint publications

M Maas